Nutralife Biosciences Inc (NLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,312 | -2,501 | -2,890 | -1,910 | -1,338 |
| Depreciation Amortization | 344 | 144 | 1,066 | 938 | 729 |
| Accounts receivable | 81 | 38 | -141 | -17 | -6 |
| Accounts payable and accrued liabilities | 93 | 9 | 1 | -3 | 19 |
| Other Working Capital | 227 | 52 | 40 | 21 | -132 |
| Other Operating Activity | 2,938 | 1,903 | 640 | 66 | 39 |
| Operating Cash Flow | $-630 | $-356 | $-1,284 | $-906 | $-689 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 458 | 458 | 1,160 | 830 | 600 |
| Debt Repayment | -10 | -5 | -20 | -15 | -10 |
| Common Stock Issued | 193 | N/A | 130 | 130 | 125 |
| Financing Cash Flow | $641 | $454 | $1,270 | $945 | $715 |
| Beginning Cash Position | 1 | 1 | 15 | 15 | 15 |
| End Cash Position | 13 | 98 | 1 | 55 | 41 |
| Net Cash Flow | $12 | $97 | $-14 | $40 | $26 |
| Free Cash Flow | |||||
| Operating Cash Flow | -630 | -356 | -1,284 | -906 | -689 |
| Free Cash Flow | -630 | -356 | -1,284 | -906 | -689 |